Predictors of medication-refill adherence in an indigent rural population

Medical Care

Volumn 40, Issue 12, 2002, Pages 1294-1300

  Schectman, Joel M ^a   Bovbjerg, Viktor E ^b   Voss, John D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adherence; Drug therapy; Race; Socioeconomic status

Indexed keywords

ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRESCRIPTION; REGRESSION ANALYSIS; RURAL POPULATION; SOCIAL CLASS; SOCIOECONOMICS; TREATMENT REFUSAL; UNITED STATES;

DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MEDICAL INDIGENCY; MIDDLE AGED; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS; RURAL POPULATION; SOCIAL CLASS; TREATMENT REFUSAL; VIRGINIA;

EID: 0036884214     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200212000-00016     Document Type: Article

References (57)

1. Cramer JA. Relationship between medication adherence and medical outcomes. Am J Health Syst Pharm 1995;52:527-529.
2. Bond WS, Hussar DA. Detection methods and strategies for improving medication adherence. Am J Hosp Pharm 1991;48:1978-1988.
3. Rudd P. Clinicians and patients with hypertension: unsettled issues about adherence. Am Heart J 1995;130:572-579.
4. Polednak AP. Racial and ethnic differences in disease. New York, NY: Oxford University Press; 1989.
5. Curry CL. Coronary artery disease in African-Americans. Circulation 1991;83:1474-1475.
6. Johnson PA, Lee TH, Cook EF, et al. Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med 1993;118:593-601.
7. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, et al. Racial differences in the use of revascularization procedures after coronary angiography. JAMA 1993;269:2642-2646.
8. Eggers PW, Greenberg LG. Racial and ethnic differences in hospitalization rates among aged Medicare beneficiaries, 1998. Health Care Fin Rev 2000;21:91-105.
9. Brown CM, Segal. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med 1996;43:903-917.
10. Green-Hennessy S, Hennessy KD. Demographic differences in medication use among individuals with self-reported major depression. Psychiat Services 1999;50:257-259.
11. Langer N. Culturally competent professionals in therapeutic alliances enhance patient compliance. J Health Care Poor Underserved 1999;10:19-26.
12. Johnson KH, Bazargan M, Bing EG. Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus. Arch Fam Med 2000;9:964-970.
13. Bamberger JD, Unick J, Klein P, et al. Helping the urban poor stay with antiretroviral drug therapy. Am J Pub Health 2000;90:699-701.
14. Betancourt JR, Carrillo JE, Green AR. Hypertension in multicultural and minority populations: linking communication to compliance. Current Hypertension Reports 1999;1:482-488.
15. Jack L Jr, Liburd L, Vinicor F, et al. Influence of the environmental context on diabetes self-management: a rationale for developing a new research paradigm in diabetes education. Diab Educator 1999;25:775-780.
16. Ahluwalia JS, McNagny SE, Kanuru NK. A randomized trial to improve follow-up care in severe uncontrolled hypertensives at an inner-city walk-in clinic. J Health Care Poor Underserved 1996;7:377-389.
17. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an innercity minority population. Am J Pub Health 1992;82:1607-1612.
18. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med 1997;12:7-14.
19. Turner J, Wright E, Mendella L,. Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest 1995;108:394-400.
20. Hill MM, Bone LR, Kim MT, et al. Barriers to hypertension care and control in young urban black men. Am J Hypertension 1999;12:951-958.
21. Rose LE, Kim MT, Dennison CR, et al. The contexts of adherence for African Americans with high blood pressure. J Advanced Nursing 2000;32:587-594.
22. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services - A review of barriers to quality care. Cancer 1999;86:2378-2390.
23. Crane LA. Social support and adherence behavior among women with abnormal pap smears. J Cancer Educ 1996;11:164-173.
24. Bess CJ. Abilities and limitations of adult type II diabetic patients with integrating self-care practices into their daily lives [dissertation] Birmingham, AL: University of Alabama University; 1995.
25. NIH RFA: HL-01-005. Overcoming barriers to treatment adherence in minorities and persons living in poverty. Available at: http://grants.nih.gov/ grants/guide/rfa-files/RFA-HL-01-005.html
26. Brach C, Fraser I. Can cultural competency reduce racial and ethnic health disparities? A review and conceptual model. Med Care Res Rev 2000;57(Suppl 1):181-217.
27. Fiscella K, Franks P, Gold MR, et al. Inequality in quality - Addressing socioeconomic, racial, and ethnic disparities in health care. JAMA 2000;283:2579-2584.
28. Haynes RB. A critical review of the 'determinants' of patient compliance with therapeutic regimens. In: Sackett DL, Haynes RB, eds. Compliance with therapeutic regimens. Baltimore, MD: Johns Hopkins University Press; 1976:26-39.
29. Steiner JF, Prochazka AV. The assessment of refill adherence using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-116.
30. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: Adherence by the elderly. Am J Public Health 1993;83:711-716.
31. Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;154:433-437.
32. Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race. Am J Public Health 1996;86:1805-1808.
33. Bailey JE, Lee MD, Somes GW, et al. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Therapeutics 1996;18:1252-1262.
34. Choo PW. Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-857.
35. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-1090.
36. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill Count, Self-Report, and Pharmacy Claims. Data to measure medication adherence in the elderly. Ann Pharmacother 1998;32:749-754.
37. Christensen DB, Williams B, Goldberg HI, et al. Assessing adherence to antihypertensive medication using computer-based pharmacy records. Med Care 1997;25:1164-1170.
38. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000;20:941-949.
39. Steiner JF, Fihn SD, Blair B, et al. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol 1991;44:1361-1371.
40. Hamilton RA, Briceland LL. Use of prescription-refill records to assess patient compliance. Am J Hosp Pharm 1992;49:1691-1696.
41. Deyo RA, Inui TS, Sullivan B. Noncompliance with arthritis drugs: magnitude, correlates and clinical implications. J Rheumatol 1981;8:931-936.
42. Laine C, Newschaffer CJ, Zhang DZ, et al. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis. Obstet Gyn 2000;95:167-173.
43. Gornick ME. Disparities in Medicare services: Potential causes, plausible explanations, and recommendations. Health Care Financing Rev 2000;21:23-43.
44. Blendon RJ, Scheck AC, Donelan K, et al. How white and African-Americans view their health and social problems -difference experiences, different expectations. JAMA 1995;273:341-346.
45. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA 1999;282:583-589.
46. LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev 2000;57(Suppl 1):146-161.
47. Doescher MP, Saver BG, Franks P, et al. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med 2000;9:1156-1163.
48. Clark NM, Becker MH. Theoretical models and strategies for improving adherence and disease management. In: Shumaker SA, Schron EB, Ockene JK, McBee WL, ed. The Handbook of Health Behavior Change, 2nd ed. New York, NY: Springer; 1998:5-32.
49. Fiscella K, Franks P, Clancy CM. Skepticism toward medical care and health care utilization. Med Care 1998;36:180-189.
50. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001;16:793-799.
51. Smith NL, Psaty BM, Heckbert SR, et al. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 1999;52:143-146.
52. Dunbar-Jacob JM, Schlenk EA, Burke LE, et al. Predictors of patient adherence: Patient characteristics. In: Shumaker SA, Schron EB, Ockene JK, McBee WL, eds. The Handbook of Health Behavior Change, 2nd ed. New York, NY: Springer: 1998;491-511.
53. Caron HS. Adherence: the case for objective measurement. J Hypertens Suppl 1985;3:S11-S17.
54. Bond WS, Hussar DA. Detection methods and strategies for improving medication adherence. Am J Hosp Pharm 1991;48:1978-1988.
55. Miller LG, Honghu L, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy. J Gen Inter Med 2002;17:1-11.
56. DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 12:93-102.
57. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-895.